Literature DB >> 8441467

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.

J Mosser1, A M Douar, C O Sarde, P Kioschis, R Feil, H Moser, A M Poustka, J L Mandel, P Aubourg.   

Abstract

Adrenoleukodystrophy (ALD) is an X-linked disease affecting 1/20,000 males either as cerebral ALD in childhood or as adrenomyeloneuropathy (AMN) in adults. Childhood ALD is the more severe form, with onset of neurological symptoms between 5-12 years of age. Central nervous system demyelination progresses rapidly and death occurs within a few years. AMN is a milder form of the disease with onset at 15-30 years of age and a more progressive course. Adrenal insufficiency (Addison's disease) may remain the only clinical manifestation of ALD. The principal biochemical abnormality of ALD is the accumulation of very-long-chain fatty acids (VLCFA) because of impaired beta-oxidation in peroxisomes. The normal oxidation of VLCFA-CoA in patients' fibroblasts suggested that the gene coding for the VLCFA-CoA synthetase could be a candidate gene for ALD. Here we use positional cloning to identify a gene partially deleted in 6 of 85 independent patients with ALD. In familial cases, the deletions segregated with the disease. An identical deletion was detected in two brothers presenting with different clinical ALD phenotypes. Candidate exons were identified by computer analysis of genomic sequences and used to isolate complementary DNAs by exon connection and screening of cDNA libraries. The deduced protein sequence shows significant sequence identity to a peroxisomal membrane protein of M(r) 70K that is involved in peroxisome biogenesis and belongs to the 'ATP-binding cassette' superfamily of transporters.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441467     DOI: 10.1038/361726a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  278 in total

1.  Effluxed lipids: Tangier Island's latest export.

Authors:  M W Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  4th Symposium on Probing Disorders of the White Matter. Abstracts.

Authors: 
Journal:  J Mol Neurosci       Date:  1999-06       Impact factor: 3.444

Review 3.  Disorders related to peroxisomal membranes.

Authors:  J Gärtner
Journal:  J Inherit Metab Dis       Date:  2000-05       Impact factor: 4.982

4.  X-linked adrenoleukodystrophy: first report of the Italian Study Group.

Authors:  A Di Biase; S Salvati; C Avellino; M Cappa; E Bertini; I Moroni; M Rimoldi; G Uziel
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 5.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

6.  Multiple-drug-resistance phenomenon in the yeast Saccharomyces cerevisiae: involvement of two hexose transporters.

Authors:  A Nourani; M Wesolowski-Louvel; T Delaveau; C Jacq; A Delahodde
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 7.  CFTR and TNR-CFTR expression and function in the kidney.

Authors:  Jackson Souza-Menezes; Geórgia da Silva Feltran; Marcelo M Morales
Journal:  Biophys Rev       Date:  2014-05-07

Review 8.  CFTR structure and function: is there a role in the kidney?

Authors:  J Souza-Menezes; M M Morales
Journal:  Biophys Rev       Date:  2009-01-17

9.  A missense point mutation (Ser515Phe) in the adrenoleukodystrophy gene in a family with adrenomyeloneuropathy: a clinical, biochemical, and genetic study.

Authors:  M Vorgerd; S Fuchs; M Tegenthoff; J P Malin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

10.  Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts.

Authors:  N Cartier; J Lopez; P Moullier; F Rocchiccioli; M O Rolland; P Jorge; J Mosser; J L Mandel; P F Bougnères; O Danos
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.